Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 164Recruiting 47Terminated 37Active not recruiting 31Unknown 17Not yet recruiting 8Withdrawn 6Approved for marketing 4Enrolling by invitation 2Suspended 1No longer available 1Available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 21Other hematologic neoplasm 15Genitourinary 14Breast 14Other solid neoplasm 12Thoracic 11Lymphoid 10Dermatologic 10Gynecologic 8Tumor-Agnostic 7CNS 7Sarcoma 4Myeloid 4Plasma cell 3Head & Neck 2Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1Neoplasms 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Endocrine × Clear all
NCT04418167 2025-09-03

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

JS InnoPharm, LLC

Phase 1 Suspended
71 enrolled
DermatologicEndocrineHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡